Tenative signs that European countries may be learning to manage COVID-19. Last week US Federal Reserve Chair Jerome Powell announced a revised framework for US monetary policy. We see it as ringing in a new, potentially inflationary, era. August was a bumper month for stock markets, the latest in a strong run since April.
As of the start of September there have been almost 26 million cases of COVID-19 and 850,000 recorded fatalities.
The US has recorded 6 million cases – around a quarter of the total according to Johns Hopkins University – and the administration’s handling of the virus remains a key issue in the election. The focus has actually been on the evolution of the virus in Europe in recent weeks given a worrying rise in cases, but according to the World Health Organization, there are “encouraging signs” that countries in Europe are learning how to manage the virus:
“Europe has learned how to identify, isolate, quarantine … It’s also identified how to put in place the individual measures so we’ve already seen in some areas of Europe a very rapid reversal in what were some rapidly increasing curves”
Over the last week, the flash release of data on consumer prices in the Eurozone in August was the most significant piece of data, with the eurozone falling back into deflation territory as inflation fell by -0.2%, down from 0.4% in July.
In terms of the numbers, the pace of deflation in energy prices moderated from -8.4% to -7.8% in August, with energy prices flat on the month. Meanwhile, the pace of food inflation slowed from 2% to 1.7% and services inflation slowed from 0.9% to 0.7%. However, the major development was in core goods inflation, which stood at 0.2% in June, 1.6% in July and -0.1% in August – a rollercoaster ride driven by a delay in the timing of summer sales this year.
The recent cut in the rate of VAT in Germany has no doubt contributed to the weakness of core inflation. However, given the recent appreciation of the euro, the large margin of spare capacity in the economy and the risks of inflation expectations becoming detached there are good reasons to suppose that it will remain weak in the medium-term.
On the policy front, last week marked the beginning on a new era in US monetary policy and the end of an era in Japanese politics.
Chair Powell used his presentation at the virtual Jackson Hole conference to unveil the key conclusions of the Federal Reserve’s strategy review. The bottom line for investors is that the Federal Reserve will adopt a flexible average inflation targeting framework which in Chair Powell’s words means that:
“following periods when inflation has been running below 2 %, appropriate monetary policy will likely aim to achieve inflation moderately above 2 % for some time.”
This change was widely anticipated and the implications are broadly understood by the market: interest rates will likely stay low for a number of years as exit from the lower bound will be delayed to facilitate that period of moderately above target inflation. However, a couple of key points are worth emphasising.
Meanwhile, in Japan Prime Minister Shinzo Abe has announced that he will be stepping down as both President of the Liberal Democratic Party and as Prime Minister on grounds of ill health.
It is no secret that Abe has suffered from an incurable inflammatory bowel condition (ulcerative colitis) throughout his adult life. Indeed, the medical condition was the cause of his resignation in 2007. However, his health had become an increasingly frequent topic of conversation in the Japanese media in recent weeks, and in particular the claim that Abe had visited hospital several times in recent weeks.
It is hard to over-play Shinzo Abe’s importance. He has just surpassed the record set by Eisaku Satō as the longest serving Japanese Prime Minister. He has become so personally associated with Japan’s economic strategy for managing demographic change and escaping deflation that everyone refers to the plan as Abenomics. But it is not just economics. Abe has also shaped Japan’s role on the world stage and its relationships with the two global super-powers, China and the United States.
Abe’s successor will be chosen by the Liberal Democratic Party, which is the dominant force in Japanese politics. That process will take place over the next couple of weeks with the chosen candidate being elected prime minister by the lower house of parliament on 16 September. At this stage, Yoshihide Suga is the politician most likely to succeed Abe.
We suspect that the succession will lead to less change in macroeconomic policy than investors may have initially feared. In the short run there is little alternative to the current strategy of the Bank of Japan, unless policymakers are willing to accept a significant correction in the exchange rate and equity prices. Indeed, if anything, the stance of fiscal policy may be eased further. The direction of the domestic reform agenda or Japan’s approach to foreign policy is a little less clear.
In August stock indices performed very well. The MSCI World Index of stocks in developed nations rose 6.6% in August, the strongest August rally since 1986. The broader MSCI All-Country World index that includes emerging market stocks rose 6.3% in August, its best month of August since 1988.
The S&P 500 index rose 7.01% (its strongest August since 1986 when it rose 7.1%) having, over the course of the month of August, erased the last of its pandemic losses and struck an all-time high. For the S&P, August was the fifth consecutive monthly rise. This represents the longest period of positive consecutive monthly performance for the S&P since 1938.
Stock markets in Germany, France, Italy and Spain rose by between 4 and 7% in August on a euro basis. In Asia, Japan’s Topix rose 8.2% on the month, and China’s CSI 300 returned 2.6% in local currency terms (source of all data is BNP Paribas Asset Management as of 31/08/2020).
This strong run for stocks again raises concerns about a potential discrepancy between market valuations and the still fragile state of the global economy.
Any views expressed here are those of the author as of the date of publication, are based on available information, and are subject to change without notice. Individual portfolio management teams may hold different views and may take different investment decisions for different clients. This document does not constitute investment advice.
The value of investments and the income they generate may go down as well as up and it is possible that investors will not recover their initial outlay. Past performance is no guarantee for future returns.
Investing in emerging markets, or specialised or restricted sectors is likely to be subject to a higher-than-average volatility due to a high degree of concentration, greater uncertainty because less information is available, there is less liquidity or due to greater sensitivity to changes in market conditions (social, political and economic conditions).
Some emerging markets offer less security than the majority of international developed markets. For this reason, services for portfolio transactions, liquidation and conservation on behalf of funds invested in emerging markets may carry greater risk.
Investments in the aforementioned fund are subject to market fluctuation and risks inherent in investing in securities. The value of investments and the revenue they generate can increase or decrease and it is possible that investors will not recover their initial investment. Source: BNP Paribas Asset Management.
UCITS OFFER NO GUARANTEED RETURNS AND PAST PERFORMANCES DO NOT GUARANTEE FUTURE ONES